Literature DB >> 26898545

Development of a biphasic dissolution test for Deferasirox dispersible tablets and its application in establishing an in vitro-in vivo correlation.

Amal Al Durdunji1, Hatim S AlKhatib1, Mutasim Al-Ghazawi2.   

Abstract

In a biphasic dissolution medium, the integration of the in vitro dissolution of a drug in an aqueous phase and its subsequent partitioning into an organic phase is hypothesized to simulate the in vivo drug absorption. Such a methodology is expected to improve the probability of achieving a successful in vitro-in vivo correlation. Dissolution of Dispersible tablets of Deferasirox, a biopharmaceutics classification system type II compound, was studied in a biphasic dissolution medium using a flow-through dissolution apparatus coupled to a paddle apparatus. The experimental parameters associated with dissolution were optimized to discriminate between Deferasirox dispersible tablets of different formulations. The dissolution profiles obtained from this system were subsequently used to construct a level A in vitro-in vivo correlation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biphasic dissolution medium; Deferasirox; Flow-through apparatus; In vitro/in vivo correlations; Paddle apparatus

Mesh:

Substances:

Year:  2016        PMID: 26898545     DOI: 10.1016/j.ejpb.2016.02.006

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  2 in total

1.  Solid Dispersion Pellets: An Efficient Pharmaceutical Approach to Enrich the Solubility and Dissolution Rate of Deferasirox.

Authors:  Ali Farmoudeh; Anahita Rezaeiroshan; Mohammadreza Abbaspour; Ali Nokhodchi; Pedram Ebrahimnejad
Journal:  Biomed Res Int       Date:  2020-06-23       Impact factor: 3.411

2.  A Solid Ultra Fine Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) of Deferasirox for Improved Solubility: Optimization, Characterization, and In Vitro Cytotoxicity Studies.

Authors:  Alaa Alghananim; Yıldız Özalp; Burcu Mesut; Nedime Serakinci; Yıldız Özsoy; Sevgi Güngör
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.